SLC2A1 and neoplasm: Specifically, overexpression of glucose transporter 1 (GLUT1) and pyruvate dehydrogenase kinase 1 (PDHK1) in hypoxic conditions promotes anaerobic glycolysis, leading to lactate production that acidifies the TME and facilitates tumor progression, drug resistance, metastasis, and immune escape [21].